VHIR participates in a trial in patients to test a drug for Huntington’s disease August 2, 2019 9:59 am Published by ondeuev
Characterized a key protein for the formation of the Central Nervous System, common among invertebrates and vertebrates August 2, 2019 9:55 am Published by ondeuev
Adding low-intensity chemotherapy treatment for six months significantly increases survival rate in children with rhabdomyosarcoma August 2, 2019 9:49 am Published by ondeuev
Transplanting intestinal microbiota corrects the portal hypertension on Non Alcoholic Fatty Liver Disease (NASH) August 2, 2019 9:46 am Published by ondeuev
Vall d’Hebron leads the first clinical trial in Spain to treat acute spinal cord injuries with mesenchymal stem cells August 2, 2019 9:45 am Published by ondeuev
A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d’Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe August 2, 2019 9:43 am Published by ondeuev
VHIR researchers describe a pathway to slow Parkinson’s disease progression and reverse the symptoms August 2, 2019 9:40 am Published by ondeuev
A large-scale genetic study offers a new vision of the causes of stroke August 2, 2019 9:38 am Published by ondeuev
Dr. Xavier Montalban leads the first European Clinical Practice Guide in Multiple Sclerosis August 2, 2019 9:36 am Published by ondeuev
Dr. Chaysavanh Manichanh receives a fellowship of the Crohn’s and Colitis Foundation of America August 2, 2019 9:33 am Published by ondeuev